Company page
Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc. is a public company traded under the ticker XLO in the American market. The company has a market capitalization of approximately $58.4 million. Xilio focuses on developing innovative therapies to improve patient outcomes in cancer treatment.
- Ticker
- XLO:NASDAQ
- Asset type
- Stock
- Market cap
- $59.2M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD